Evidence map›Paper›PMID 41517125›Full record

ReviewFoods (Basel, Switzerland)2025

Clinical Potential of

Samuel Abiodun Kehinde, Zahid Naeem Qaisrani, Rinrada Pattanayaiying, Bo Bo Lay, Khin Yadanar Phyo, Wai Phyo Lin, Myat Mon San, Nurulhusna Awaeloh, Sasithon Aunsorn, Ran Kitkangplu and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Samuel Abiodun KehindeBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0000-0003-3768-906X
Zahid Naeem QaisraniBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Rinrada PattanayaiyingDepartment of Food Innovation and Professional Chef, Faculty of Science and Technology, Suan Sunandha Rajabhat University, Bangkok 10300, Thailand.ORCID 0000-0002-4254-5637
Bo Bo LaySchool of Information Technology, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Khin Yadanar PhyoBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0009-0008-4013-8908
Wai Phyo LinBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0009-0008-4776-3001
Myat Mon SanBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Nurulhusna AwaelohThai Faculty of Allied Health Science, Nakhon Ratchasima College, Nakhon Ratchasima 30000, Thailand.
Sasithon AunsornBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0009-0008-5025-4590
Ran KitkangpluBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0009-0002-8409-1677
Sasitorn ChusriBiomedical Technology Research Group for Vulnerable Populations and School of Health Science, Mae Fah Luang University, Chiang Rai 57100, Thailand.ORCID 0000-0002-7365-6890

Funding

"Program Management Unit for Competitiveness (PMUC)" (Grant No. C02F670127) and the Postdoctoral Fellowship Fund from Mae Fah Luang University, Thailand (Contract No. 10/2025). (Grant No. C02F670127) and (Contract No. 10/2025).
6 · The paper itself

Abstract

Metabolic syndrome (MetS) and its associated conditions, namely, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), obesity, and polycystic ovary syndrome (PCOS) are characterized by insulin resistance, dyslipidemia, and low-grade inflammation. Curcumin, a polyphenolic compound derived from

Indexed as

antioxidantCurcuma longacurcumininflammationlipid profilemetabolic syndromenutraceuticalsrandomized controlled trialtype 2 diabetes

Identifiers

PMID41517125
PMCPMC12785604

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.